CirculoGene Theranostics: Funding, Investors & Team (Oct 2026)
CirculoGene is a company in the biotechnology industry that has expertise in the areas of cfDNA, tumor monitoring, laboratory testing, molecular diagnostics and liquid biopsy. The lab they developed for cfDNA, cRNA, and MSI liquid biopsies is unique to them. CIRCULOGENE, their proprietary test is a next-generation sequencing process that can analyze a full genomic load from one standard tube of blood within one week. This technology is beneficial because it allows clinicians and their patients to make informed decisions about targeted therapies, monitor effectiveness and anticipate any possible relapse. They were established in 2015 and their headquarters are located in Birmingham, Alabama.
CirculoGene Theranostics has raised $2.8M across 2 funding rounds on record, the most recent an undisclosed round of $2.0M announced in Mar 2023.
That round is below the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
CirculoGene Theranostics Company Profile and Key Stats
Latest funding round on record: Mar 2023.
CirculoGene Theranostics Funding Rounds
CirculoGene Theranostics raised $750k in a Debt Financing announced in Aug 2022.
7 months later, an undisclosed round of $2.0M was announced in Mar 2023.
CirculoGene Theranostics Founders and Leadership Team
No contact details are on record for this team yet.
CirculoGene Theranostics Funding Compared to Other Biotechnology Startups
CirculoGene Theranostics' latest round of $2.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like CirculoGene Theranostics in Biotechnology and Birmingham
Companies Similar to CirculoGene Theranostics
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
CirculoGene Theranostics Funding FAQs
What does CirculoGene Theranostics do?
CirculoGene is a company in the biotechnology industry that has expertise in the areas of cfDNA, tumor monitoring, laboratory testing, molecular diagnostics and liquid biopsy. The lab they developed for cfDNA, cRNA, and MSI liquid biopsies is unique to them. CIRCULOGENE, their proprietary test is a next-generation sequencing process that can analyze a full genomic load from one standard tube of blood within one week. This technology is beneficial because it allows clinicians and their patients to make informed decisions about targeted therapies, monitor effectiveness and anticipate any possible relapse. They were established in 2015 and their headquarters are located in Birmingham, Alabama.
How much funding has CirculoGene Theranostics raised?
CirculoGene Theranostics has raised $2.8M across 2 rounds on record. The most recent is an undisclosed round of $2.0M announced in Mar 2023.
When did CirculoGene Theranostics last raise funding?
CirculoGene Theranostics' most recent funding round on record is an undisclosed round of $2.0M, announced in Mar 2023.
Who founded CirculoGene Theranostics?
FundedIQ lists Chen Hsiung Yeh (Founder) at CirculoGene Theranostics.
Who is the CEO of CirculoGene Theranostics?
Michael Mullen is listed as CEO at CirculoGene Theranostics.
Where is CirculoGene Theranostics headquartered?
CirculoGene Theranostics is based in Birmingham, Alabama, United States.
How many employees does CirculoGene Theranostics have?
CirculoGene Theranostics is in the 11-50 employee band.
How does CirculoGene Theranostics' funding compare to other Biotechnology startups?
CirculoGene Theranostics' latest round of $2.0M is below the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's CirculoGene Theranostics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for CirculoGene Theranostics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.